A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

Insulin-producing human pancreas cells can be manufactured with 3D printers, researchers reported at the International Transplant Congress underway in London.

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

An experimental once-weekly insulin known as efsitora has shown comparable effectiveness to daily insulin regimens in ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...